Detection of Cell Wall Galactomannoprotein Afmp1p in Culture Supernatants of Aspergillus fumigatus and in Sera of Aspergillosis Patients
暂无分享,去创建一个
P. Woo | K. Yuen | Che-man. Chan | S. Lau | Liang Cao | Samson S. Y. Wong | X. Che | A. Leung | C. Chan | S. Wong
[1] L. Tissi,et al. Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. , 1988, Journal of general microbiology.
[2] K. Yuen,et al. Characterization of AFMP1: a Novel Target for Serodiagnosis of Aspergillosis , 2001, Journal of Clinical Microbiology.
[3] K. Yuen,et al. Detection of Antibodies Specific to an Antigenic Cell Wall Galactomannoprotein for Serodiagnosis of Aspergillus fumigatus Aspergillosis , 2002, Journal of Clinical Microbiology.
[4] A. Mencacci,et al. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice , 1994, Infection and immunity.
[5] K. Yuen,et al. Detection of Cell Wall Mannoprotein Mp1p in Culture Supernatants of Penicillium marneffei and in Sera of Penicilliosis Patients , 1999, Journal of Clinical Microbiology.
[6] K. Yuen,et al. Detection of Specific Antibodies to an Antigenic Mannoprotein for Diagnosis of Penicillium marneffeiPenicilliosis , 1998, Journal of Clinical Microbiology.
[7] F. Urbani,et al. Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans. , 1993, The Journal of infectious diseases.
[8] A. Casadevall,et al. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages , 1995, Infection and immunity.
[9] Yongmoon Han,et al. Antibody response that protects against disseminated candidiasis , 1995, Infection and immunity.
[10] J. Latgé,et al. Aspergillus fumigatus and Aspergillosis , 1999, Clinical Microbiology Reviews.
[11] G. Verhoef,et al. Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis , 1999, Journal of Clinical Microbiology.
[12] J. Djeu,et al. Identification of a mannoprotein fraction from Candida albicans that enhances human polymorphonuclear leukocyte (PMNL) functions and stimulates lactoferrin in PMNL inhibition of candidal growth. , 1992, The Journal of infectious diseases.
[13] K. Yuen,et al. Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] K. Wong,et al. Differences in Clinical and Laboratory Diagnostic Characteristics of Penicilliosis Marneffei in Human Immunodeficiency Virus (HIV)- and Non-HIV-Infected Patients , 2001, Journal of Clinical Microbiology.
[15] A. Casadevall,et al. Antibody immunity and invasive fungal infections , 1995, Infection and immunity.
[16] K. Yuen,et al. DNA immunization using a secreted cell wall antigen Mp1p is protective against Penicillium marneffei infection. , 2002, Vaccine.
[17] D. Denning,et al. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. , 1990, Reviews of infectious diseases.
[18] M. Puliti,et al. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. , 1991, Cellular immunology.
[19] K. Yuen,et al. MP1 Encodes an Abundant and Highly Antigenic Cell Wall Mannoprotein in the Pathogenic Fungus Penicillium marneffei , 1998, Infection and Immunity.